Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Expenses:    
General and Administrative $ 4,663,146 $ 8,277,993
Research and Development 4,027,037 3,448,925
In-Process R&D Impairment 1,904,314 0
Change in Fair Value of Contingent Consideration 1,992,399 582,605
Total Operating Expenses 12,586,896 12,309,523
Operating Loss Before Other Income (12,586,896) (12,309,523)
Other Income (Expense), Net:    
Change in Fair Value of Warrant Liability 0 (1,425,102)
(Loss) Gain on Disposal of Fixed Assets (28,379) 4,211
Interest Income 173,989 56,891
Interest Expense (11,132) (8,599)
Other Income (Expense), Net 28,841 (14,498)
Total Other Income (Expense), Net 163,319 (1,387,097)
Loss Before Income Tax (Expense) Benefit (12,423,577) (13,696,620)
Income Tax (Expense) Benefit (90,319) 113,010
Net Loss (12,513,896) (13,583,610)
Deemed Dividends from Warrant Reset Provision (530,985) 0
Net Loss Attributable to Common Shareholders, basic (13,044,881) (13,583,610)
Net Loss Attributable to Common Shareholders, diluted $ (13,044,881) $ (13,583,610)
Net Loss per Common Share - Basic (in usd per share) $ (2.69) $ (18.55)
Net Loss per Common Share - Diluted (in usd per share) $ (2.69) $ (18.55)
Weighted Average Shares Outstanding - Basic (in shares) 4,842,067 732,303
Weighted Average Shares Outstanding - Diluted (in shares) 4,842,067 732,303
Other Comprehensive Loss:    
Net Loss $ (12,513,896) $ (13,583,610)
Foreign Currency Translation Adjustments (60) (96,310)
Comprehensive Loss $ (12,513,956) $ (13,679,920)